GI
ONC icon

Gradient Investments’s BeOne Medicines Ltd ONC Stock Holding History

Gradient Investments’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3
Closed -$541 – 1879
2023
Q4 		$541 Hold
3
– – ﹤0.01% 1577
2023
Q3 		$540 Hold
3
– – ﹤0.01% 1540
2023
Q2 		$535 Buy
+3
New +$691 ﹤0.01% 1521

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return

Gradient Investments's ONC Position: Q1 2024 in Review

Gradient Investments sold out of BeOne Medicines Ltd (ONC) in Q1 2024, closing a stake of 3 shares — an estimated $541 sold.

Gradient Investments first reported a position in ONC in Q2 2023 and held it in 3 quarters. The position peaked at $541 in Q4 2023. 205 funds tracked by Wall St. Rank hold ONC as of Q1 2024.

  • Gradient Investments reported no remaining BeOne Medicines Ltd position as of Q1 2024 after selling out during the quarter.
  • Gradient Investments sold 3 BeOne Medicines Ltd shares in Q1 2024, an estimated $541.
  • Gradient Investments first reported a position in BeOne Medicines Ltd in Q2 2023 and held it in 3 quarters.
  • Gradient Investments's BeOne Medicines Ltd position peaked at $541 in Q4 2023.
  • 205 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2024.

Based on Gradient Investments's 13F filing for Q1 2024, filed 23 Apr 2024.